Clinical trials
Triple Negative Breast Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
129 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 10 |
| 2016 | 3 |
| 2017 | 9 |
| 2018 | 11 |
| 2019 | 18 |
| 2020 | 18 |
| 2021 | 13 |
| 2022 | 12 |
| 2023 | 16 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 129 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 20 |
| Chinese Academy of Medical Sciences | 8 |
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| Tianjin Medical University Cancer Institute and Hospital | 3 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2 |
| Infinity Pharmaceuticals, Inc. | 2 |
| Istituti Ospitalieri di Cremona | 2 |
| Ministry of Health, Saudi Arabia | 2 |
| Northwestern University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 129 |
| Breast Neoplasms | 45 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Ovarian Neoplasms | 7 |
| Stomach Neoplasms | 7 |
| Endometrial Neoplasms | 6 |
| Carcinoma, Renal Cell | 4 |
| Colorectal Neoplasms | 4 |
| Melanoma | 4 |
| Sarcoma | 4 |
Trials
Showing 76 to 100 of 129. Each trial links to its page on Pharma Observatory.
29 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.